AbbVie, Inc. (ABBV)
222.44
-0.82
(-0.37%)
USD |
NYSE |
Feb 10, 16:00
222.33
-0.11
(-0.05%)
Pre-Market: 08:58
AbbVie EPS Diluted (Quarterly) : 1.024 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.45 |
| Biogen, Inc. | -0.3333 |
| Gilead Sciences, Inc. | 2.434 |
| Johnson & Johnson | 2.098 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.815B |
| Revenue (Quarterly) | 16.62B |
| Total Expenses (Quarterly) | 14.80B |
| Enterprise Value | 456.25B |
| Gross Profit Margin (Quarterly) | 84.02% |
| Profit Margin (Quarterly) | 10.92% |
| Earnings Yield | 1.06% |
| Operating Earnings Yield | 5.12% |
| Normalized Earnings Yield | 3.148 |